Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on August 5.

Exemptés pour l’heure de droits de douane, les industriels pharmaceutiques craignent des surtaxes vertigineuses.

Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on August 5.